The hepoxilin analog, PBT-3, inhibits growth of K-562 CML solid tumours in vivo in nude mice

In Vivo

Volumn 19, Issue 1, 2005, Pages 185-190

  Li, Xiang ^a   Qiao, Na ^a   Reynaud, Denis ^a   Abdelhaleem, Mohamed ^a   Pace Asciak, Cecil R ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; CML; Hepoxilin analogs; K 562; PBT 3

Indexed keywords

DNA; DRUG VEHICLE; HYDROXY FATTY ACID; IMATINIB; PBT 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DNA DETERMINATION; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; SOLID TUMOR; TUMOR GROWTH;

EID: 16244400473     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pace-Asciak CR, Granström E and Samuelsson B: Arachidonic acid epoxides: Isolation and structure of 2 hydroxy epoxide intermediates in the formation of 8,11,12-trihydroxy eicosatrienoic acid and 10,11,12-trihydroxy eicosatrienoic acid. J Biol Chem 258: 6835-6840, 1983.
2. Pace-Asciak CR: Arachidonic acid epoxides. Demonstration through oxygen-18 labeled oxygen gas studies of an intramolecular transfer of the terminal hydroxyl group of 12S-hydroperoxy-eicosa-5,8,10,14-tetraenoic acid to form hydroxy epoxides. J Biol Chem 259: 8332-8337, 1984.
3. Pace-Asciak CR and Martin JM: Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets. Prostagl Leukotriene Med 16: 173-180, 1984.
4. Dho S, Grinstein S, Corey EJ, Su WG and Pace-Asciak CR: Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils. Biochem J 266: 63-68, 1990.
5. Laneuville O, Reynaud D, Grinstein S, Nigam S and Pace-Asciak CR: Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4. Biochem J 295: 393-397, 1993.
6. Pace-Asciak CR, Mizuno K and Yamamoto S: Resolution by DEAE cellulose chromatography of the enzymatic steps in the transformation of arachidonic acid into 8,11,12-trihydroxy eicosatrienoic acid and 10,11,12-trihydroxy eicosatrienoic acid by rat lung. Prostaglandins 25 79-84, 1983.
7. Pace-Asciak CR, Klein J and Spielberg SP: Epoxide hydratase assay in human platelets using hepoxilin A3 as a lipid substrate. Biochim Biophys Acta 875: 406-409, 1986.
8. Pace-Asciak CR and Lee W-S: Purification of hepoxilin epoxide hydrolase from rat liver. J Biol Chem 264: 9310-9313, 1989.
9. Pace-Asciak CR, Laneuville O, Chang M, Reddy CC, Su W-G and Corey EJ: New products in the hepoxilin pathway: isolation of 11-glutathionyl hepoxilin A3 through reaction of hepoxilin A3 with glutathione S-transferase. Biochem Biophys Res Commun 163: 1230-1234, 1989.
10. Pace-Asciak CR, Laneuville O, Su W-G, Corey EJ, Gurevich N, Wu P and Carlen PL: A glutathione conjugate of hepoxilin A3: Formation and action in the rat central nervous system. Proc Natl Acad Sci (USA) 87: 3037-3041, 1990.
11. Demin PM and Pace-Asciak CR: Synthesis of racemic 11,12-cyclopropyl analogs of hepoxilins A3 and B3. Tetrahedron Lett 34 4305-4308, 1993.
12. Jankov RP, Luo X, Demin P, Aslam R, Hannam V, Tanswell AK and Pace-Asciak CR: Hepoxilin analogs inhibit bleomycin-induced pulmonary fibrosis in the mouse. J Pharm Exp Ther 301: 435-440, 2002.
13. Qiao N, Reynaud D, Demin P, Halushka PV and Pace-Asciak CR: The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPa isoform in transfected COS-7 cells. J Pharm Exper Therap 307: 1142-1147, 2003.
14. Pace-Asciak CR, Reynaud D, Demin P, Aslam R and Sun A: A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition. J Pharm Exper Ther 301: 618-624, 2002.
15. Reynaud D, Hinek A and Pace-Asciak CR: The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP. FEBS Lett 515: 58-60, 2002.
16. Reynaud D, Clark D, Qiao N, Rand ML and Pace-Asciak CR: The hepoxilin stable analogue, PBT-3, inhibits primary, platelet-related hemostasis in whole blood measured in vitro with the PFA-100. Thromb Res 112: 245-248, 2003.
17. Qiao N, Lam J, Reynaud D, Abdelhaleem M and Pace-Asciak CR: The hepoxilin analog PBT-3 induces apoptosis in BCR-ABL-positive K562 leukemia cells. Anticancer Res 23: 3617-3622, 2003.
18. Le Coutre P, Mologni L, Cleris L, Marchesi E, Buchdunger E, Giardini R, Formelli F and Gambacorti-Passerini CJ: In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. J Natl Cancer Inst 91: 163-168, 1999.
19. Takagi M, Honmura T, Watanabe S, Yamaguchi R, Nogawa M, Nishimura I, Katoh F, Matsuda M and Hidaka H: In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176. Invest New Drugs 21: 387-399, 2003.
20. Li X, Xu J, Guo M, Mori E and Mori T: Apoptotic cell death of human gastric tumor induced by nucleosides from CD57+HLA-DRbright natural suppressor cell line. Int J Oncol 14: 687-694, 1999.
21. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
22. Beere HM, Chresta CM, Alejo-Herberg A, Skladanowski A, Dive C, Larsen AK and Hickman JA: Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol Pharmacol 47: 986-996, 1995.
23. Kroemer G, Petit P, Zamzami N, Vayssiere JL and Mignotte B: The biochemistry of programmed cell death. FASEB J 9: 1277-1288, 1995.
24. Rich IN, Worthington-White D, Garden OA and Musk P: Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. Blood 15: 1427-1434, 2000.
25. Li X, Guo M, Mori E and Mori T: Activation of caspase-3 in molt4 cells by apoptosis-inducing nucleosides from CD57(+)HLA-DR(bright) natural suppressor cell line. Biochem Biophys Res Commun 268: 514-520, 2000.